Skip to content

Pilot study on early intervention of traditional Chinese medicine in metabolic syndrome people with dampness syndrome

Pilot study on early intervention of traditional Chinese medicine in metabolic syndrome people with dampness syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035323
Enrollment
Unknown
Registered
2020-08-08
Start date
2020-08-06
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Meet the diagnosis of dampness syndrome; 3. Meet the diagnosis of metabolic syndrome; 4. Volunteer to participate in the research of this subject and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Secondary blood sugar caused by nephrotic syndrome, hypothyroidism, renal failure, liver disease, systemic lupus erythematosus, myeloma, glycogen accumulation, lipodystrophy, acute porphyria and polycystic ovary syndrome , Patients with abnormal blood lipids and blood pressure. 2. Patients with abnormal blood glucose and lipids caused by drugs (phenothiazines, ß-blockers, adrenal corticosteroids, etc.) 3. After treatment, the systolic blood pressure is still >= 180mmHg or the diastolic blood pressure is still>= 110mHg. 4. The blood glucose is still >= 11.1mmol/L after drug treatment. 5. After oral drug treatment, TC >= 6.22mmol/L (240 mg/d L) or LDL-C >= 4.92 mmol/L (190mg/d L) or TG >= 3.39 mmol/L. 6. Patients with malignant tumors, severe heart disease, blood system disease, cerebrovascular accident, severe trauma or major surgery. 7. Women who are pregnant or breastfeeding or who plan to become pregnant during the trial period or whose spouse plans to become pregnant. 8. People with allergies, possible allergies to this medicine, or mental illness. 9. Others who cannot cooperate for a long time.

Design outcomes

Primary

MeasureTime frame
waist;BMI;Bp;GLU;INS;LDL-C;HDL-C;TC;TG;UA;CRP;HbA1C;

Secondary

MeasureTime frame
TNF-a;IL-6;intestinal microflora;Metabonomics;

Countries

China

Contacts

Public ContactZhimin Yang

Guangdong Provincal Traditional Chinese Medical Hospital

yangyo@163.net+86 13822296363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026